Evotec SE Refines 2024 Guidance; Expects Revenues Of €790-820M, R&D Expenditures Of €50-60M, And Adjusted EBITDA Of €15-35M; Lower Guidance Due To Slower Sales Conversion And High Fixed Costs, But Business Transformation On Track For Sustainable Growth
Portfolio Pulse from Benzinga Newsdesk
Evotec SE has refined its 2024 guidance, expecting revenues of €790-820M, R&D expenditures of €50-60M, and adjusted EBITDA of €15-35M. The lower guidance is due to slower sales conversion and high fixed costs, but the company is on track for sustainable growth.
August 06, 2024 | 7:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evotec SE has lowered its 2024 guidance due to slower sales conversion and high fixed costs. The company expects revenues of €790-820M, R&D expenditures of €50-60M, and adjusted EBITDA of €15-35M. Despite the lower guidance, the business transformation is on track for sustainable growth.
The lower guidance indicates potential short-term challenges for Evotec SE, such as slower sales conversion and high fixed costs. This could negatively impact investor sentiment and the stock price in the short term. However, the company's focus on sustainable growth may mitigate some concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100